Objective: This study examines the prevalence and predictors of deterioration during the three months following treatment in Project MATCH (Matching Alcoholism Treatments to Client Heterogeneity), a multisite clinical trial of three different treatments for alcohol-use disorders.
Method: The outpatient and aftercare samples of Project MATCH were examined to identify the prevalence of deterioration, as reflected by a decline in percent days abstinent between the 3 months prior to baseline and the 3 months immediately following treatment. Analyses of predictors of deterioration were based on baseline sociodemographic and psychological factors, including substance-related and psychiatric symptoms and treatment-related factors, including treatment type, treatment duration and therapeutic alliance.
Results: Approximately 10% (91/927) of patients in the outpatient sample and 7% (50/738) of patients in the aftercare sample deteriorated in the 3 months following treatment. Primary predictors of deterioration in the outpatient sample were lower baseline severity of alcohol dependence, higher baseline depression, fewer sessions of treatment and lower ratings of therapeutic alliance. The only factor associated with deterioration in the aftercare sample was fewer sessions of treatment.
Conclusions: Despite the general positive response of patients to alcohol-use disorder treatment, researchers and treatment providers need to be aware of the potential for deterioration in a sizable minority of patients. Potential methods for identifying patients at risk for deterioration early in treatment are discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.15288/jsa.2005.66.517 | DOI Listing |
Eur J Neurol
February 2025
Neurodegenerative Diseases Group, Biobizkaia Health Research Institute, Barakaldo, Spain.
Background: Patients with post-COVID condition (PCC) and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) experience symptoms potentially associated with small fiber neuropathy (SFN).
Methods: A sample of 90 participants, comprising 30 PCC patients, 30 ME/CFS patients, and 30 healthy controls (HC), matched by sex and age, was assessed. Neuropathic, autonomic, and fatigue symptoms were measured with TaskForce Monitor, the Sudoscan, heat and cold evoked potentials, In Vivo Corneal Confocal Microscopy (IVCCM), and specialized questionaries.
Genet Epidemiol
March 2025
Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, Yahaba, Japan.
The polygenic score (PGS) holds promise for motivating preventive behavioral changes. However, no clinically validated standardization methodology currently exists. Here, we demonstrate the efficacy of a "reference-based" approach for standardization.
View Article and Find Full Text PDFAutism Res
January 2025
Genome Center, University of California, Davis, CA, USA.
Among autistic individuals, a subphenotype of disproportionate megalencephaly (ASD-DM) seen at three years of age is associated with co-occurring intellectual disability and poorer prognoses later in life. However, many of the genes contributing to ASD-DM have yet to be delineated. In this study, we identified additional ASD-DM candidate genes with the aim to better define the genetic etiology of this subphenotype of autism.
View Article and Find Full Text PDFEmerg Med Australas
February 2025
School of Health and Social Development, Deakin University Faculty of Health, Melbourne, Victoria, Australia.
Objective: Children with non-accidental injuries have increased risk of future death. There is insufficient evidence for widespread physical abuse screening tool use in the ED. This study assesses the utility of a physical abuse project that includes the implementation of a screening tool with case-matching from multiple sources.
View Article and Find Full Text PDFSmall
January 2025
The Faculty of Printing, Packaging Engineering and Digital Media Technology, Xi'an University of Technology, Xi'an, 710048, P. R. China.
The susceptibility to freezing of the electrolyte and mismatched cathode make the aqueous zinc-ion hybrid supercapacitors (ZHSCs) have inferior electrochemical performance at low temperature. Herein, a novel freeze-tolerant hydrogel electrolyte (CEEZ) and matched graphene/porous carbon/cellulose nanofibers cathode (GPCN) are respectively fabricated via chemical cross-linking and a two-step process to assemble ZHSCs. The prepared electrode has a highly porous structure, abundant edge active sites, and increased interlayer spacing, which collectively reduces ion transport complexity and enhances the contact area with the electrolyte, promoting rapid ionic conduction pathways.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!